Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D
基于下一代测序的MSI评分可预测错配修复缺陷型肿瘤患者接受纳武利尤单抗治疗的获益：NCI-MATCH Z1D组随访研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0427
Schoenfeld, Jonathan D; Azad, Nilofer S; Gross, Jacob; Chen, Li; Overman, Michael J; Kao, Katrina; Jackson, Latifa; Brunnquell, Donna; Bu, Xiangning; Coppola, Christina; Guan, Ping; Lee, Jennifer; Sims, David; Fuchs, Rebecca; Weirather, Jason L; Pfaff, Kathleen L; Gunasti, Lauren; Ranasinghe, Srin; Hamilton, Stanley R; Wang, Victoria; O'Dwyer, Peter J; Wu, Catherine J; Rodig, Scott J; Patton, David R; Harris, Lyndsay
